Brachytherapy Systems, Women's Healthcare

Brachytherapy is important to women's health because it is a common treatment for cervical, breast, and skin cancer.

  • Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI Scout surgical guidance system. The technology uses real-time audible and visual indicators to give surgeons a precise way to target tissue during lumpectomy and excisional biopsy procedures.

  • Researchers found older women with invasive breast cancer treated with brachytherapy were at higher risk for a later mastectomy compared to women treated with standard ...

  • This Oncentra brachy treatment plan shows the applicator in relation to the anatomy.

    The ability of magnetic resonance imaging (MRI) to create exquisite images of the body’s soft tissues – and the tumors that arise amid them – is helping physicians at the National Cancer Center Singapore (NCCS) to precisely shape brachytherapy doses to cervical tumors, while at the same time...

  • May 9, 2011 - Initial findings from the SAVI Collaborative Research Project (SCRP), on SAVI radiation therapy for breast cancer, were presented at the recent annual meeting of the American Brachytherapy Society (ABS).

  • APBI: A Rapidly Evolving Technology

    A recent development in breast radiation oncology targets specific tumor regions and delivers the necessary radiation in a shorter time period. Accelerated partial breast irradiation (APBI), an alternative radiation treatment to traditional whole breast radiation therapy, reduces the treated...

About 40,920 women in the U.S. are expected to die from breast cancer this year
Blog | Breast Imaging | October 03, 2018

According to BreastCancer.org, an estimated 266,120 new cases of invasive...

Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018

October 2, 2018 — Breast cancer recurrence rates for patients treated with the Xoft Axxent...

​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018

World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and...

Intraoperative Radiotherapy Provides Lifetime Cost Savings, Health Benefits for Early-Stage Breast Cancer Treatment
News | Brachytherapy Systems, Women's Healthcare | December 19, 2017

December 19, 2017 — iCAD Inc. announced the results of a landmark study that showed the benefits of adjunct...

Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017

October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines...

International Trial Confirms Safety, Effectiveness of High-Dose Brachytherapy Plus Pelvic Radiation for Cervical Cancer
News | Brachytherapy Systems, Women's Healthcare | October 04, 2017

October 4, 2017 — Findings from a new multicenter, international clinical trial confirm the effectiveness of...

Pelvic Radiation Confirmed as Standard of Care for High-Risk, Early-Stage Endometrial Cancer
News | Brachytherapy Systems, Women's Healthcare | September 28, 2017

September 28, 2017 — In a new phase III trial report, recurrence-free and overall survival rates for women with...

China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017

August 30, 2017 — iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from...

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017

August 3, 2017 — Researchers presented ...

Australia's Monash Cancer Centre Treats First Early-Stage Breast Cancer Patient With Xoft System
News | Brachytherapy Systems, Women's Healthcare | May 01, 2017

May 1, 2017 — iCAD Inc. announced the first early-stage breast cancer patient was treated in Australia with...

New Clinical Data on Xoft System Presented at American Brachytherapy Society Annual Meeting
News | Brachytherapy Systems, Women's Healthcare | April 20, 2017

April 20, 2017 — iCAD Inc. announced that updated clinical data on the use of...

Concure Oncology, Breast Microseed Treatment, one day, low-dose rate brachytherapy, LDR
Technology | Brachytherapy Systems, Women's Healthcare | May 12, 2016

May 12, 2016 — Concure Oncology/Breast Microseed Inc. announced the launch of its one-time, one-hour...

News | Brachytherapy Systems, Women's Healthcare | April 20, 2016

April 20, 2016 — Cianna Medical Inc. announced new clinical data evaluating the Savi Scout...

Gamma pro, kubtec
News | Breast Imaging | November 04, 2015

Kubtec announced the launch of the Gamma-Pro Node and Seed Location System for use in breast seed location and...

iCAD, Xoft Axxent, electronic brachytherapy, eBx, clinical studies, ASTRO 2015, radiation therapy

Xoft Axxent image courtesy of iCAD Inc.

News | Brachytherapy Systems | October 21, 2015

October 21, 2015 — iCAD Inc. presented updated clinical data, hosted in-booth clinician presentations and showcased...

Theragenics, Advanced Radiation Therapy LLC, AccuBoost, early stage breast cancer, brachytherapy
News | Brachytherapy Systems, Women's Healthcare | August 07, 2015

August 7, 2015 — Theragenics Corp. has reached an agreement with Advanced Radiation Therapy LLC to distribute the...

Cianna Medical, SAVI Scout, breast surgical guidance system

Photo courtesy of Cianna Medical

Technology | December 16, 2014

December 16, 2014 — Cianna Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for the SAVI...

Clinical trial/study, radiation therapy, brachytherapy systems, women's health

Image courtesy of iCAD

News | December 16, 2014

December 16, 2014 — iCAD, Inc. announced that more than 500 patients have been treated in its...

Strut-based Brachytherapy Breast Cancer Treatment Cianna Medical ASTRO
News | September 17, 2014

September 17, 2014 — Cianna Medical Inc. announced five-year results for the first 200 hundred patients treated with...